secwatch.observer — SEC 8-K summary
======================================

Issuer:     P3 Health Partners Inc. (PIII)
CIK:        0001832511
Form:       8-K
Filed at:   2026-04-28T23:59:59+00:00
Accession:  0001832511-26-000018
Event type: regulatory
Sentiment:  positive
Materiality: 0.85
Item codes: 1.01, 3.02, 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

P3 converts ~$252.5M debt to preferred stock, raises $10M to regain Nasdaq equity compliance
--------------------------------------------------------------------------------

- Exchanged ~$252.5M promissory notes for Series A/B/C preferred stock (13.5%-19.5% dividends) to boost stockholders' equity.
- Secured up to $70M in Series D preferred plus warrants from largest holder CPF; initial $10M tranche closed.
- Standstill extended to Jan 1, 2027; CPF may designate independent director if ownership exceeds 40%.
- Special committee negotiated transactions; intended to satisfy Nasdaq minimum equity requirement.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1832511/000183251126000018/0001832511-26-000018-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1832511/000183251126000018/piii-20260427.htm
  HTML page:      https://secwatch.observer/filing/0001832511-26-000018

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer